Articles
Topical administration of a novel mouth rinse, AG013, appears safe, well tolerated, and effective in reducing the severity and course of oral mucositis (OM) in patients receiving induction chemotherapy in a study presented at the 2012 ASCO Annual Meeting (Abstract 9024).
A new appreciation of the pathobiological foundation of mucositis, and the application of genomics to risk assessment, heralds an individualized and more effective approach to intervention for this costly, often disabling, toxicity, according to specialists who spoke at a session on mucosal injury during the 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO).
Higher levels of anxiety in men who undergo surgical removal of prostate cancer appear to be linked to poor sexual satisfaction and depression, say researchers. A recent Mayo Clinic study determined that men who experience high levels of “cancer-specific anxiety” within 1 year of surgery for prostate cancer could likely benefit from counseling for anxiety, depression, and to improve their quality of life.
More than 10 years after diagnosis, women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease, according to a Kaiser Permanente study.
Treating breast cancer in postmenopausal women with aromatase inhibitors leads to high degrees of sexual difficulties. These side effects include low interest, insufficient lubrication, and pain with intercourse, according to researchers from Örebro University and Uppsala University in Sweden.
Researchers have discovered a significant link between antibodies for multiple oral bacteria and the risk of pancreatic cancer.
The study, published in the journal Gut, found that high antibody levels for an infectious periodontal bacterium strain of Porphyromonas gingivalis were associated with double the risk for pancreatic cancer. Conversely, a 45% lower risk of pancreatic cancer was associated with high levels of antibodies for harmless “commensal” oral bacteria.
Despite the fact that most survivors of adolescent and young adult cancers have health insurance, many avoid routine medical care because it’s too expensive, according to a new study published early online in Cancer. Thus, simply increasing insurance coverage for young cancer survivors may not be enough to preserve their long-term health.
A new report states that in spite of declining death rates, cancer has exceeded heart disease as the leading cause of death among Hispanics in the US. According to American Cancer Society researchers, 29,935 people of Hispanic origin in the US died of cancer in 2009, compared with 29,611 deaths from heart disease that same year.
In 2012, an estimated 112,800 new cases of cancer will be diagnosed and 33,200 cancer deaths will occur among Hispanics, the largest and fastest growing major demographic group in the US.